Core Viewpoint - The legal opinion confirms that the 2024 Annual General Meeting of China People's Insurance Group Co., Ltd. was convened and conducted in accordance with relevant Chinese laws and regulations, ensuring the legitimacy and validity of the meeting and its resolutions [4][6][8]. Group 1: Meeting Procedures - The notice for the 2024 Annual General Meeting was published on June 6, 2025, in compliance with the requirements of the Shanghai Stock Exchange and other relevant media [5][6]. - The meeting utilized a combination of on-site and online voting, with online voting available from 9:15 AM to 3:00 PM on the day of the meeting [5][6]. Group 2: Voting Participation - A total of 16 shareholders (including proxies) participated in the on-site voting, representing 36,203,920,642 shares, which is 81.86% of the total voting shares [6]. - The combined results from on-site and online voting showed participation from 731 shareholders, representing 36,547,844,714 shares, or 82.64% of the total voting shares [6][8]. Group 3: Voting Procedures and Results - The meeting reviewed several proposals, including amendments to the company's articles of association and various reports for the fiscal year 2024 [7][8]. - All proposals except for the special resolution were passed by a simple majority, while the special resolution required a two-thirds majority and was also approved [8]. Group 4: Conclusion - The legal opinion concludes that the meeting's convening, participation, and voting procedures were all in compliance with the Company Law and the company's articles of association, affirming the legality and validity of the meeting and its resolutions [4][8].

EF001 | Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this | | | --- | --- | | howsoever arisen from or in reliance upon the whole or any part of the contents of this announcement. | announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss | | Cash Dividend Announcement for Equity Issuer | | | Instrument | Equity issuer | | Issuer name | The People's I ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 喻 強 宋洪軍 1339 董事名單與其角色和職能 一、執行董事 丁向群 （董事長） 趙 鵬 （副董事長） 肖建友 二、非執行董事 王清劍 苗福生 王少群 三、獨立非執行董事 邵善波 徐麗娜 王鵬程 高平陽 - 1 - 四、董事會專業委員會 | 董事會下設五個董事會專業委員會，各董事會專業委員會的組成如下： | | --- | | | 委員會 | | 風險管理與 | | | | | --- | --- | --- | --- | --- | --- | --- | | | | 戰略與投資 | 消費者權益 | 審計 | 提名薪酬 | 關聯交易 | | 董事 | | 委員會 | 保護委員會 | 委員會 | 委員會 | 控制委員會 | | 丁向群 | | C | | | | | | 趙 鵬 | | | C | | | | | 肖建友 | | | | | | M | | 王清劍 | | M | | M | | | ...

证券代码：601319 证券简称：中国人保 公告编号：2025-021 中国人民保险集团股份有限公司 2024年度股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一)股东会召开的时间：2025 年 6 月 27 日 (二)股东会召开的地点：北京市西城区西长安街 88 号中国人保大厦 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 731 | | --- | --- | | 股股东人数 其中：A | 729 | | 境外上市外资股股东人数（H 股） | 2 | | 2、出席会议的股东所持有表决权的股份总数（股） | 36,547,844,714 | | 其中：A 股股东持有股份总数 | 32,680,460,996 | | 股） 境外上市外资股股东持有股份总数（H | 3,867,383,718 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | 82.642575% ...

FANGDA PARTNERS http://www.fangdalaw.com 关于中国人民保险集团股份有限公司 2024 年度股东会的法律意见书 致：中国人民保险集团股份有限公司 上海市方达（北京）律师事务所（以下简称"本所"）是具有中华人民共和国 境内法律执业资格的律师事务所。根据相关法律顾问协议，本所指派律师出席中 国人民保险集团股份有限公司（以下简称"公司"）2024 年度股东会（以下简称"本 次股东会"），并就本次股东会的召集和召开程序、参与表决和召集会议人员的资 格、表决程序和表决结果等有关事宜出具本法律意见书。 本法律意见书依据《中华人民共和国公司法》（以下简称"《公司法》"）、《中 华人民共和国证券法》《上市公司股东会规则》及其他相关中华人民共和国境内 已公开颁布并生效的法律、法规、规章及规范性文件（以下合称"中国法律法规"， 仅为本法律意见书说明之目的，不包括中国香港特别行政区、中国澳门特别行政 区和中国台湾地区的法律、法规）以及《中国人民保险集团股份有限公司章程》 （以下简称"《公司章程》"）的规定出具。 本法律意见书仅就本次股东会的召集和召开程序、出席会议人员、召集人、 表决程序是否符 ...

证券代码：601319 证券简称： 中国人保 公告编号：临 2025-022 中国人民保险集团股份有限公司 第五届董事会第十次会议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完 整性承担法律责任。 本公司第五届董事会第十次会议（以下简称"会议"）的通知和 材料于 2025 年 6 月 9 日以书面方式通知全体董事，会议于 2025 年 6 月27日在北京市西城区西长安街88号中国人保大厦以现场会议方式 召开。会议应出席董事 12 名，现场出席 10 名，委托出席 2 名。丁向 群董事、赵鹏董事委托肖建友董事出席会议并表决。会议由肖建友董 事主持。监事会成员及部分高级管理层成员列席了会议。会议的召开 符合《中华人民共和国公司法》等相关法律、行政法规、部门规章和 《中国人民保险集团股份有限公司章程》的规定，会议合法、有效。 经与会董事审议并表决，形成以下会议决议： 一、审议通过了《关于制定<中国人民保险集团股份有限公司合 规管理办法>的议案》 表决结果：12 票同意，0 票反对，0 票弃权。 二、审议通过了《关于制定<中国人民保险集团投资资产 ...

Core Viewpoint - The second batch of insurance fund long-term investment pilot projects has officially commenced, with TaiKang Asset being the first institution to announce its investment activities [1][3]. Group 1: Investment Initiatives - TaiKang Asset has completed its first investment transaction through its wholly-owned private equity fund management company, TaiKang Stable [2][3]. - The long-term investment pilot allows insurance companies to invest in private equity funds, primarily targeting the secondary market for stocks and holding them long-term [3]. - TaiKang Life and TaiKang Asset were approved by the financial regulatory authority in January to participate in the long-term investment pilot, with an approved amount of 12 billion yuan [3]. Group 2: Investment Strategy - TaiKang Stable's investment strategy focuses on three main directions: high dividend assets, industrial upgrades, and counter-cyclical buying [4]. - The strategy emphasizes fundamental analysis to achieve medium to long-term stable asset appreciation, supporting high-quality economic development and stable capital market operations [4]. - The investment will prioritize sectors with stable operations and consistent dividends, as well as areas aligned with national development strategies, such as high-end manufacturing, artificial intelligence, and biomedicine [4]. Group 3: Pilot Program Expansion - The second and third batches of insurance fund pilot projects are being progressively implemented, with a total of 222 billion yuan approved across three batches [5][7]. - Eight insurance companies have been approved in the second batch, with a total scale of 112 billion yuan, while the third batch has a scale of 60 billion yuan [5][7]. - The pilot program aims to facilitate long-term investments by insurance companies, addressing previous barriers and enhancing their equity investment capabilities [7].

Core Viewpoint - The insurance sector in A-shares and Hong Kong stocks has shown significant growth, with major companies experiencing substantial stock price increases, driven by a shift towards participating insurance products and regulatory guidance aimed at stabilizing the market [1][2][3]. Group 1: Market Performance - On June 25, A-shares saw all three major indices rise, with the Shanghai Composite Index increasing by 1.04%, reaching a new high for the year [1]. - The insurance sector led the gains, with companies like New China Life and China Pacific Insurance rising over 3%, and China Life increasing by more than 2% [1]. - In Hong Kong, insurance stocks also performed well, with China Pacific Insurance rising over 5% and New China Life and China Taiping both increasing by over 4% [1]. Group 2: Regulatory Environment - The China Banking and Insurance Regulatory Commission issued guidelines to life insurance companies, emphasizing prudent management and discouraging excessive competition in dividend levels [1][2]. - The guidelines aim to stabilize the market by ensuring that companies do not artificially inflate dividend levels, which could disrupt the insurance market [1][2]. Group 3: Industry Trends - The transition towards participating insurance products is expected to begin in 2025, with a focus on floating yield products [2]. - Analysts predict that the adjustment of preset interest rates and the integration of individual insurance reporting will impact premium growth rates, with a potential increase in the attractiveness of participating insurance [2]. - The regulatory measures are seen as beneficial for controlling the floating cost levels of participating insurance, thereby reducing long-term risks associated with interest rate differentials [2]. Group 4: Future Outlook - Analysts expect that the new business value (NBV) growth rate will decline compared to 2024, but the quality of operations is anticipated to improve [3]. - The insurance sector is viewed as having long-term investment potential, with the ability to withstand market fluctuations and support capital market development [3]. - The target demographic for insurance products is shifting towards wealthier individuals from the 60s and 70s, with participating insurance products likely to become central in wealth management [3].

Core Viewpoint - The Chinese government has issued guidelines to enhance health insurance services, expand coverage, and integrate commercial health insurance with health management, which aligns with the strategic direction of the insurance industry [1][2]. Group 1: Policy and Market Context - The State Council's recent guidelines emphasize improving health insurance service levels and expanding coverage to include new medical technologies and drugs [1]. - The implementation of the DRG reform marks a significant opportunity for commercial health insurance to supplement basic medical insurance, especially in light of rising major disease incidences [2]. Group 2: Product Innovations - China Life Health has upgraded its flagship products, "Good Insurance Long-term Medical (Flagship Version 2025)" and "Good Insurance Middle-aged and Elderly Long-term Medical (2025 Version)," to better meet market demands and government calls for expanded insurance services [2][3]. - The upgraded products now include coverage for advanced medical facilities and a broader range of hospitals, significantly enhancing access to high-quality medical care for users [3]. Group 3: Advanced Medical Coverage - The advanced medical equipment list has been expanded from 202 to 1501 items, covering all newly approved drugs and specific cross-border medical devices, allowing for 100% reimbursement under certain conditions [4]. - The products offer a long-term renewal guarantee for cancer and specific cardiovascular diseases, ensuring stable coverage for patients requiring ongoing treatment [4]. Group 4: Health Management Services - The introduction of a "Family Doctor" service module enhances the existing health management offerings, providing users with comprehensive health services, including 24/7 online consultations and chronic disease management [5]. - This integration of insurance and health management reflects a shift towards comprehensive health management, aligning with national policy requirements [5]. Group 5: Commitment to Health and Innovation - China Life Health aims to address the gaps in coverage created by the DRG/DIP payment system through product innovation, demonstrating a commitment to high-quality insurance services and the health of the population [6]. - The company is focused on enhancing customer experience and ensuring that financial services contribute positively to the well-being of families, supporting the broader goals of the health insurance industry [6].

Core Viewpoint - The Ministry of Agriculture and Rural Affairs of China has announced the top ten innovative financial support models for agriculture in 2024, with "China Pacific Insurance's comprehensive agricultural insurance products supporting farmland protection and quality improvement" being recognized as one of the innovative models [1] Group 1: Innovative Products - China Pacific Insurance has developed three major insurance products: quality defect liability insurance for high-standard farmland construction, comprehensive insurance for farmland facility damage, and soil fertility index insurance, providing comprehensive protection for transforming ordinary farmland into high-yield farmland [2] - The quality defect liability insurance for high-standard farmland construction covers material damage caused by quality defects and natural disasters, as well as repair costs due to operational failures [2] - As of the end of 2024, these three agricultural insurance products have been promoted in all 31 provinces, providing risk coverage of 14.4 billion yuan for quality defect liability insurance, 2.9 billion yuan for comprehensive insurance, and over 800 million yuan for soil fertility index insurance, with total claims exceeding 135 million yuan [3] Group 2: Service Innovation - China Pacific Insurance has introduced professional services to enhance farmland facility management, intervening throughout the entire process of farmland construction, management, and maintenance [4] - The company has established specialized service teams in Sichuan Province to conduct risk assessments and provide maintenance suggestions, resulting in the identification of 585 risk points and 164 hidden risks in completed projects in 2024 [4] Group 3: Technology Empowerment - The company is enhancing service efficiency through technology, developing a "Farmland Management" platform that integrates risk control technology for digital processes and online operations [5][6] - The platform allows for the recording of insured farmland project information and facilitates regular inspections and risk reporting through a mobile app [6] Group 4: Risk Reduction - China Pacific Insurance is shifting its insurance model from traditional loss compensation to risk reduction, exploring integrated service mechanisms that combine preemptive measures and post-event compensation [7] - In Liaoning Province, the company is promoting soil quality improvement by providing farmers with free materials for soil enhancement and technical guidance from third-party soil restoration companies [7]